Fabrinet Other Non-Current Liabilities increased by 41.3% to $13.05M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 290.8%, from $3.34M to $13.05M. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a -1.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.44M | $3.28M | $2.79M | $2.47M | $2.41M | $1.34M | $1.48M | $1.53M | $2.08M | $2.18M | $1.97M | $2.06M | $2.21M | $2.93M | $3.25M | $3.34M | $3.28M | $6.72M | $9.24M | $13.05M |
| QoQ Change | — | -4.8% | -14.9% | -11.6% | -2.4% | -44.5% | +10.2% | +3.8% | +35.9% | +4.8% | -9.6% | +4.4% | +7.3% | +32.4% | +11.0% | +2.9% | -1.8% | +104.9% | +37.5% | +41.3% |
| YoY Change | — | — | — | — | -30.1% | -59.2% | -47.2% | -37.9% | -13.6% | +63.0% | +33.7% | +34.5% | +6.2% | +34.1% | +64.6% | +62.2% | +48.4% | +129.7% | +184.5% | +290.8% |